Frankfurt, Germany

Joachim Tillner

This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Sanofi. Active years: 2013-2014.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joachim Tillner: Innovator in Medicinal Chemistry

Introduction

Joachim Tillner is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on crystalline solvates and polymorphs of specific compounds.

Latest Patents

Tillner holds 2 patents, with his latest inventions focusing on the compound 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride. The first patent relates to crystalline solvates of this compound, detailing processes for their preparation and potential applications. The second patent introduces new crystalline polymorphs of the same compound, emphasizing their use in the preparation of medicaments.

Career Highlights

Joachim Tillner is currently associated with Sanofi, a global healthcare leader. His work at Sanofi has allowed him to explore and develop innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Tillner has collaborated with esteemed colleagues such as Norbert Nagel and Bruno Baumgartner, contributing to a dynamic research environment.

Conclusion

Joachim Tillner's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor in the pharmaceutical field. His work continues to pave the way for advancements in drug development and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…